Looc, Baby Girl .

HRN: 27-46-63  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/15/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/15/2025
07/24/2025
IV
21mg
Q36
RDS
Checking Initial Appropriateness 
07/15/2025
CEFOTAXIME 500MG (VIAL)
07/15/2025
07/22/2025
IV
70mg
Q12
Rds
Checking Initial Appropriateness 
07/17/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/17/2025
07/23/2025
IV
21mg As LD Then 11mg As MD
OD
T/c NEC Vs Ileus
Checking Initial Appropriateness 
07/18/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/18/2025
07/25/2025
IV
140mg
Q8H
Sepsis
Checking Initial Appropriateness 
07/20/2025
MUPIROCIN 2%, 15G (TUBE)
07/20/2025
07/26/2025
TOPICAL
-
BID
Infected Wound
Waiting Final Action 
08/06/2025
CEFTAZIDIME 1GM (VIAL)
08/06/2025
08/12/2025
IVT
55mg
Q12H
RDS
Checking Initial Appropriateness 
08/08/2025
FLUCONAZOLE 50MG (CAP)
08/08/2025
08/15/2025
PO
7mg
3x/week
Sepsis
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: